Change from baseline
| Aclidinium 400 µg BID | Placebo | Δ | |
| Adjusted LS mean (95% CI), Week 3 | |||
| Endurance time, s | 68.3 (31.1, 105.6) | 9.8 (-27.8, 47.4) | 58.5* (9.0, 108.0) |
| Dyspnoea, units | -0.48 (-0.87, -0.09) | 0.15 (-0.25, 0.54) | -0.63* (-1.11, -0.14) |
| dIC, mL | |||
| At rest | 140 (78, 202) | -36 (-98, 26) | 176‡ (92, 260) |
| Isotime | 117 (58, 0.176) | -38 (-97, 21) | 155† (76, 234) |
| Peak | 119 (62, 175) | -42 (-98, 14) | 161‡ (87, 235) |
| Mean over 1 week | |||
| Daily physical activity | |||
| Active energy consumption, kcal | 22 | -33 | 55* |
| Step count, steps | 296 | -163 | 459 |
| Moderate activity, mins | 4.2 | -5.9 | 10.0* |
p<0.05, †p<0.001, ‡p<0.0001